Professor Margarida Gonçalo shared with us one of the session of the recent EADV Symposium took place in Ljubljana. The topic was chronic urticaria.

Video: https://congressreport.eu/scientific-contents/interview:treatment-options-chronic-urticaria

Professor Federico Cappuzzo summarize the program of the Summit held in Rome. During the sessions was discussed various aspects in the field of lung cancer. Like new biomarkers for prevention and screening for patients with lung cancer, neoadjuvant therapies, treatment of metastatic disease, new immunotherapy options and targeted therapies.

Video: https://congressreport.eu/scientific-contents/interview:novalites-international-summit-lung-cancer-rome

Professor Daniel Scherr co-chaired a very interesting symposium at the recent EHRA 2022 congress, how the can physicians better use the guidelines. We asked professor Scherr to summarize the most important take away messages from this symposium.

Video: https://congressreport.eu/scientific-contents/interview:atrial-fibrillation-guidelines-clinical-practice

Professor Hung-Fat Tse is an expert on the field on pacing, and recently co-chaired a very interesting symposium at the EHRA 2022 about the recent developments of conduction system pacing.

Video: https://congressreport.eu/scientific-contents/interview:recent-developments-conduction-system-pacing

Professor Michael Glikson co-chaired the European Society of Cardiology guidelines on cardiac pacing, and now he speaks for us about the part of this huge document that deals with conduction system pacing. What do the new guidelines tell us?

Video: https://congressreport.eu/scientific-contents/interview:what-do-new-guidelines-tell-us-about-conduction-system-pacing

Professor Mauro Biffi speak us about the data that were presented at the recent European Heart Rhythm Association meeting. The session he talking about was about conduction system pacing, a novel modality of cardiac stimulation.

Video: https://congressreport.eu/scientific-contents/interview:conduction-system-pacing-ready-prime-time

Professor Marc Bonaca co-moderated a session at the American College of Cardiology meeting that was focused on the care of patients with advanced vascular disease. Specifictly diseases in the lower extremities, the legs and the arms called peripheral arterial disease.

Video: https://congressreport.eu/scientific-contents/interview:antithrombotic-approaches-reduce-risk-secondary-event-cad-and-pad

Professor Mikhail Kosiborod going to speaking about the additional analysis from the EMPULSE trial that were presented at the American College of Cardiology congress. The trial demonstrated the effects of empagliflozin on symptoms, physical limitations and quality of life in patients hospitalized for acute heart failure.

Video: https://congressreport.eu/scientific-contents/interview:results-empulse-trial

Professor Deepak Bhatt had presented an analysis from the SCORED trial at the American College of Cardiology Annual Sessions as a late-breaking clinical trial.

Video: https://congressreport.eu/scientific-contents/interview:effect-sotagliflozin-cardiovascular-and-renal-events-patients-type-2-diabetes-and-moderate-renal-impairment-who-are-cardiovascular-risk-scored-trial

Professor Federico Cappuzzo gave us an update on the emerging data on the field of lung cancer. There are very important news that were presented during the ESMO, ELCC and EACR. These data are clearly changing the standard of care of patients with early stage Non-Small-Cell Lung Cancer. In this field we have data from two very important trial: the IMpower010 and the KEYNOTE-09.

Video: https://congressreport.eu/scientific-contents/standalonecontent:paradigm-shift-early-nsclc-role-icis-adjuvant-treatment